Research done by Hayashi et al., 2023 showed that GLP-1s can affect thoughts as well as cravings and metabolism, and have been reported to quiet food noise, meaning that anecdotal reports from patients and clinicians alike point to a reduction in what has been colloquially termed food noise, as patients report experiencing less rumination and obsessive preoccupation about food. The same neuroplasticity benefits that psilocybin could offer for those recovering from addiction could also be applied to those looking to rewrite their brain patterns in relation to food
While it has basic medication tracking features, Dose AI shines most in nutrition guidance
Wegovy, a higher-dose formulation of semaglutide, is specifically approved for chronic weight management and has demonstrated significant weight loss benefits in clinical trials
Spencer Nadolsky is an obesity and lipid specialist and founder of Vineyard Health Melynda Barnes, MD is a board-certified facial plastic surgeon and obesity medicine specialist and chief medical officer at Ro Sonia Gibson, MD is a board-certified endocrinologist and physician lead at Allara Health Who Is a Good Candidate for the GLP-1 Pill
Selective loss of a putative precursor population of B-Chronic Lymphocytic leukemia Cells following Immunization with hCD401/IL-2 expressing autologous tumor cells
Inhibiting glucagon release: GLP-1 prevents the release of glucagon (a hormone that raises blood sugar) from the pancreas, helping to reduce blood sugar levels
